Hyundai Bioscience Co. Ltd (048410) — Free Cash Flow Generation Index
Hyundai Bioscience Co. Ltd (048410) has a Free Cash Flow Generation Index of -1.81x as of December 2024. Free cash flow of ₩-4.09 Billion represents -2% of operating cash flow (₩2.26 Billion). Read Hyundai Bioscience Co. Ltd debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hyundai Bioscience Co. Ltd Free Cash Flow Generation Index (2008–2024)
Historical FCF Generation Index trend for Hyundai Bioscience Co. Ltd across 8 annual periods. Explore 048410 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year Free Cash Flow Generation Index for Hyundai Bioscience Co. Ltd. For the full company profile including market capitalisation, see market value of Hyundai Bioscience Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | ₩87.48 Million | ₩2.26 Billion | ₩2.17 Billion | ▲ +101.6% |
| 2020 | -2.36x | ₩-17.70 Billion | ₩7.50 Billion | ₩25.20 Billion | ▼ -433.3% |
| 2019 | -0.44x | ₩-4.06 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -118.3% |
| 2018 | 2.41x | ₩12.07 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -71.3% |
| 2015 | 8.41x | ₩734.93 Million | ₩87.36 Million | ₩647.57 Million | ▲ +398.9% |
| 2014 | 1.69x | ₩2.06 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +58.0% |
| 2011 | 1.07x | ₩4.24 Billion | ₩3.97 Billion | ₩267.78 Million | ▼ -22.5% |
| 2008 | 1.38x | ₩14.29 Billion | ₩10.37 Billion | ₩3.92 Billion | — |